Skip to content
10-Q

Quarterly Report

CALLISTO PHARMACEUTICALS INC

0001104659-11-063738

← back to feed
Filed
Nov 14, 2011 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2011 · Nov 11, 2011 158.52M sh
Capex Q3 2011 · Sep 30, 2011 $117.23K
Stockholders Equity Q3 2011 · Sep 30, 2011 $4.23M
Stockholders Equity Q3 2011 · Dec 31, 2010 $3.94M
Current Liabilities Q3 2011 · Sep 30, 2011 $8.67M
Current Liabilities Q3 2011 · Dec 31, 2010 $7.07M
Total Liabilities Q3 2011 · Sep 30, 2011 $12.53M
Total Liabilities Q3 2011 · Dec 31, 2010 $10.55M
Current Assets Q3 2011 · Sep 30, 2011 $912.56K
Current Assets Q3 2011 · Dec 31, 2010 $3.26M
Total Assets Q3 2011 · Sep 30, 2011 $1.01M
Total Assets Q3 2011 · Dec 31, 2010 $3.36M
Sga Expense Q3 2011 · Sep 30, 2011 $57.83M
Sga Expense Q3 2011 · Sep 30, 2010 $1.3M
Sga Expense Q3 2011 · Sep 30, 2010 $4.34M
Net Income Q3 2011 · Sep 30, 2011 −$121.24M
Net Income Q3 2011 · Sep 30, 2010 −$1.72M
Net Income Q3 2011 · Sep 30, 2010 −$21.61M
Operating Income Q3 2011 · Sep 30, 2011 −$117.08M
Operating Income Q3 2011 · Sep 30, 2010 −$3.6M
Operating Income Q3 2011 · Sep 30, 2010 −$12.24M
Shares Diluted Q3 2011 · Sep 30, 2010 54.5M sh
Shares Diluted Q3 2011 · Sep 30, 2010 54.27M sh
Cash And Equivalents Q3 2011 · Sep 30, 2010 $596.99K
Cash And Equivalents Q3 2011 · Dec 31, 2009 $7.21M